Evaxion Biotech As Stock Analysis

Evaxion Stock Analysis Notes

About 25.0% of the company shares are held by company insiders. The company recorded a loss per share of 2.8. Evaxion Biotech AS had not issued any dividends in recent years. The entity had 1:10 split on the 22nd of January 2024. Evaxion Biotech AS, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company was incorporated in 2008 and is headquartered in Hrsholm, Denmark. Evaxion Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 61 people. To learn more about Evaxion Biotech AS call the company at 45 31 31 97 53 or check out https://www.evaxion-biotech.com.

Evaxion Biotech AS Investment Alerts

Evaxion Biotech AS Upcoming and Recent Events

Evaxion Largest EPS Surprises

View All Earnings Estimates

Evaxion Stock Institutional Investors

Note, although Evaxion Biotech's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Evaxion Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.28 M.

Evaxion Profitablity

Management Efficiency

Evaxion Biotech AS has return on total asset (ROA) of (0.6945) % which means that it has lost $0.6945 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (8.028) %, meaning that it created substantial loss on money invested by shareholders. Evaxion Biotech's management efficiency ratios could be used to measure how well Evaxion Biotech manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to rise to 4.91 in 2024, whereas Return On Tangible Assets are likely to drop (1.80) in 2024. At this time, Evaxion Biotech's Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 2.3 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 3.4 M in 2024.

Technical Drivers

As of the 4th of December, Evaxion Biotech shows the Coefficient Of Variation of (608.38), mean deviation of 4.09, and Standard Deviation of 5.76. Evaxion Biotech AS technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Evaxion Biotech AS Price Movement Analysis

Evaxion Biotech Outstanding Bonds

Evaxion Biotech Predictive Daily Indicators

Evaxion Biotech Forecast Models

Evaxion Biotech's time-series forecasting models are one of many Evaxion Biotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Evaxion Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Evaxion Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Evaxion shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Evaxion Biotech. By using and applying Evaxion Stock analysis, traders can create a robust methodology for identifying Evaxion entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Evaxion analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Evaxion analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Evaxion Biotech AS stock analysis indicators help investors evaluate how Evaxion Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Evaxion Biotech shares will generate the highest return on investment. By understating and applying Evaxion Biotech stock analysis, traders can identify Evaxion Biotech position entry and exit signals to maximize returns.

When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.